The somatostatin analogues octreotide LAR and lanreotide Autogel have been evaluated for the treatment of acromegaly in numerous clinical trials, with considerable heterogeneity in reported biochemical response rates. This review examines and attempts to account for these differences in response rates reported in the literature.
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly / Colao, Annamaria; Auriemma, RENATA SIMONA; Pivonello, Rosario; Kasuki, Leandro; Gadelha, Mônica R.. - In: PITUITARY. - ISSN 1386-341X. - (2015). [10.1007/s11102-015-0684-z]
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
COLAO, ANNAMARIA;AURIEMMA, RENATA SIMONA;PIVONELLO, ROSARIO;
2015
Abstract
The somatostatin analogues octreotide LAR and lanreotide Autogel have been evaluated for the treatment of acromegaly in numerous clinical trials, with considerable heterogeneity in reported biochemical response rates. This review examines and attempts to account for these differences in response rates reported in the literature.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
